TCRX - TScan Therapeutics, Inc.
IEX Last Trade
3.02
-0.005 -0.166%
Share volume: 12,905
Last Updated: Fri 27 Dec 2024 08:30:31 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$3.02
0.00
-0.17%
Summary score
10%
Profitability
0%
Dept financing
11%
Liquidity
75%
Performance
3%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-16.44%
Return on assets
-9.91%
Return on sales
-1066.48%
Return on invested capital
-129.94%
Total debt ratio
37.44%
Debt ratio change over timeo
-1.66%
Current Ratio
7.06%
Quick Ratio
7.06%
Cash Position Ratio
6.78%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-15.93%
Return on assets
-9.28%
Return on sales
-1814.39%
Return on invested capital
-56.4%
Total debt ratio
43.84%
Debt ratio change over timeo
-1.68%
Current Ratio
6.3%
Quick Ratio
6.3%
Cash Position Ratio
6.01%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-24.51%
Return on assets
-13.03%
Return on sales
-5542.93%
Return on invested capital
-67.53%
Total debt ratio
48.94%
Debt ratio change over time
-2.2%
Current Ratio
5.23%
Quick Ratio
5.23%
Cash Position Ratio
5.17%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-71.59%
Return on assets
-83.81%
Return on sales
2052.14%
Return on invested capital
57.67%
Total debt ratio
-165.92%
Debt ratio change over time
-1.66%
Current Ratio
-12.01%
Quick Ratio
-12.01%
Cash Position Ratio
-11.7%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | TCRX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -16.44% | 13.79% | 34.47% | 7.43% |
| Return on assets | -9.91% | 2.76% | 3.15% | 5.62% |
| Return on sales | -1066.48% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | -129.94% | 2.36% | 5.39% | 19.77% |
| Profitability | 0% | 43% | 66% | 80% |
| Total debt ratio | 37.44% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -1.66% | 308.97% | -6.99% | 1.18% |
| Dept financing | 10% | 50% | 25% | 7% |
| Current Ratio | 6.3% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 6.3% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 6.01% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 7% | 16% | 37% |
| Short-term ratios | TCRX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -15.93% | 13.77% | 13.25% | 3.8% |
| Return on assets | -9.28% | 2.43% | 1.89% | 3.09% |
| Return on sales | -1814.39% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | -56.4% | 2.14% | 3.39% | 9.18% |
| Profitability | 0% | 71% | 68% | 82% |
| Total debt ratio | 43.84% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -1.68% | 46.38% | -72.08% | 1.51% |
| Dept financing | 12% | 50% | 25% | 7% |
| Current Ratio | 6.3% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 6.3% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 6.01% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 8% | 21% | 52% |